Answers are grounded in this paper and cite their sources.
Pulmonary embolism (PE) following arthroscopic rotator cuff repair (ARCR) is rare but can be life-threatening. Its presentation is varied, and when accompanied by elevated cardiac biomarkers and electrocardiographic abnormalities, it can be difficult to distinguish from acute coronary syndrome (ACS). This article discusses the clinical recognition of postoperative PE through two case reports. The two female patients, aged 64 and 63 years, respectively, both underwent ARCR under general anaesthesia whilst in the lateral decubitus position; the operations lasted 95 min and 90 min respectively. Case 1 developed palpitations and chest tightness on the second postoperative day; cardiac troponin I (cTnI) was 1.058 ng/mL, N-terminal pro-B-type natriuretic peptide (NT-proBNP) was 3104 pg/mL, and ST-T changes were observed on the electrocardiogram (ECG). Initial assessments suggested ACS and cardiac dysfunction; subsequent coronary CT angiography indicated a pulmonary arterial thrombus, and CT pulmonary angiography (CTPA) confirmed PE. In Case 2, cyanosis and marked hypoxaemia were first identified on the fifth postoperative day; initially, the patient did not report any chest tightness or dyspnoea. Consequently, concurrent investigations were initiated, revealing a cTnI level of 0.519 ng/mL and an NT-proBNP level of 1513 pg/mL; PE was subsequently diagnosed by CTPA. Lower-limb deep vein thrombosis was detected in both cases; in accordance with the consultation recommendations, both patients received enoxaparin for anticoagulation and were prescribed oral rivaroxaban for use after discharge. Both patients survived to discharge. Following ARCR, PE may be accompanied by elevated cardiac biomarkers and ECG abnormalities, overlapping with some of the manifestations of ACS. In patients presenting with unexplained palpitations, chest tightness, hypoxaemia or elevated cardiac biomarkers following surgery, PE should be considered alongside other causes such as ACS, and diagnostic tests should be selected based on the overall clinical probability. A single cardiac biomarker result is insufficient to diagnose or rule out PE.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: